However, the CD163/CD68 ratio was greater in NEC than in non-NEC components in 13 (39.4%) and 10 (30.3%) cases in the intra-tumoral and invasive margins, respectively (Table 3). The gene discussed is CD68; the disease is neuroendocrine carcinoma.